Search results
Results from the WOW.Com Content Network
A vaccine is available for horses. [1] This vaccine is an inactivated vaccine that uses the TC-83 strain of EEEV. [13] It is usually given in combination with vaccines for Western equine encephalitis (WEE), Venezuelan equine encephalitis (VEE), and tetanus, [4] and is also used by laboratory workers to protect from accidental exposure.
West Nile virus. West Nile fever is an infection by the West Nile virus, which is typically spread by mosquitoes. [53] In about 80% of infections people have few or no symptoms. [54] About 20% of people develop a fever, headache, vomiting, or a rash. [53]
Unlike Eastern equine encephalitis, the overall mortality of WEE is low (approximately 4%) and is associated mostly with infection in the elderly. Approximately 15–20% of horses that acquire the virus will die or be put down. [3] There is no human vaccine for WEE and there are no licensed therapeutic drugs in the U.S. for this infection.
West Nile virus. About 2 in 10 people infected with West Nile virus develop symptoms, which can include fever and swelling of the brain. About 1 in 10 people who develop severe symptoms die. There have been 216 West Nile cases so far this year. West Nile virus was first reported in the U.S. in 1999 in New York. It gradually spread across the ...
Taking an over-the-counter pain reliever like ibuprofen or acetaminophen if you experience pain or discomfort Getting plenty of rest post-vaccine to help your body recover and reduce side effects
West Nile fever is an infection by the West Nile virus, which is typically spread by mosquitoes. [1] In about 80% of infections people have few or no symptoms . [ 2 ] About 20% of people develop a fever , headache, vomiting, or a rash. [ 1 ]
The CDC lists the following as possible side effects of the RSV vaccine: Pain, redness, and swelling where the shot is given. Fatigue. Fever. Headache. Nausea. Diarrhea. Muscle or joint pain
During the 2012 West Nile virus outbreak in Texas, 1,868 cases were reported. Male patients, persons >65 years of age, and minorities were at highest risk for neuroinvasive disease. At total of 1,868 cases including 844 (45%) WNND (West Nile neuroinvasive disease) cases and 89 deaths (case-fatality rate 5%).